1 completed, 1 recruiting, 1 terminated, 1 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Primary Immune Thrombocytopenia: new trials by email Literature Review of Primary Immune Thrombocytopenia trials Research Report on Primary Immune Thrombocytopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia. Eltrombopag 25 MG, Prednisolone - Primary Immune Thrombocytopenia | Phase 1 / Phase 2 | Recruiting | Renata PLC | 100 | 2025-02-07 | 2025-02-18 |
| The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP) HMPL-523 - Immune Thrombocytopenia, Blood Platelet Disorder | Phase 1 | Withdrawn | Hutchmed | 2024-04-02 | 2025-09-16 | |
| The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects STSA-1301 subcutaneous injection, Placebo - Primary Immune Thrombocytopenia | Phase 1 | Completed | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 36 | 2023-11-16 | 2024-08-12 |
| A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347 PF-06755347 intravenous healthy participant, Placebo intravenous healthy participant, PF-06755347 subcutaneous healthy participant - Healthy, Primary Immune Thrombocytopenia | Phase 1 | Terminated | Pfizer | 58 | 2017-07-17 | 2024-07-05 |
Purpura, Thrombocytopenic, Idiopathic (4) · Autoimmune Diseases (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Hematologic Diseases (1) · Hemorrhage (1) · Hemorrhagic Disorders (1) · Immune System Diseases (1) · Pathologic Processes (1) · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1) · Purpura (1) · Purpura, Thrombocytopenic (1) · Skin Manifestations (1) · Thrombocytopenia (1) · Thrombotic Microangiopathies (1)
Cytopenia (4) · Hemic and Lymphatic Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Autoimmune Diseases (3) · Blood Coagulation Disorders (3) · Blood Platelet Disorders (3) · Hematologic Diseases (3) · Hemorrhage (3) · Hemorrhagic Disorders (3) · Immune System Diseases (3) · Pathologic Processes (3) · Purpura (3) · Purpura, Thrombocytopenic (3) · Skin Manifestations (3)
Prednisolone (1) · eltrombopag (1)
Hutchmed (1) · Pfizer (1) · Renata PLC (1) · Staidson (Beijing) Biopharmaceuticals Co., Ltd (1)
Spain (2) · United States (2) · Australia (1) · Bangladesh (1) · Belgium (1) · China (1) · Germany (1) · New Zealand (1) · Norway (1) · United Kingdom (1)
Md Manirul Islam, MBBS,FCPS (1) · Ronghua Jin, Doctor (1) · William Schelman, MD, PhD (1)
PMID 19846889, PMID 24802773, PMID 29270980, PMID 30344993, PMID 34452956
2018 (1)